The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 16, 2019
Filed:
Feb. 12, 2016
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Dongfang Meng, Morganville, NJ (US);
Hong LI, Edison, NJ (US);
Meng Yang, Westfield, NJ (US);
Manuel DE Lera Ruiz, Perkasie, PA (US);
Sunita V. Dewnani, Secaucus, NJ (US);
Tianying Jian, Westfield, NJ (US);
Dann L. Parker, Jr., Cranford, NJ (US);
Ting Zhang, Princeton Junction, NJ (US);
Louis-charles Campeau, Morris Plains, NJ (US);
Harold B. Wood, Westfield, NJ (US);
Jiayi Xu, Marlboro, NJ (US);
Richard Berger, Harleysville, PA (US);
Jane Yang Wu, Marlboro, NJ (US);
Robert K. Orr, Cranford, NJ (US);
Shawn P. Walsh, Bridgewater, NJ (US);
Bart Harper, New York, NY (US);
Dongfang Meng, Morganville, NJ (US);
Hong Li, Edison, NJ (US);
Meng Yang, Westfield, NJ (US);
Manuel de Lera Ruiz, Perkasie, PA (US);
Sunita V. Dewnani, Secaucus, NJ (US);
Tianying Jian, Westfield, NJ (US);
Dann L. Parker, Jr., Cranford, NJ (US);
Ting Zhang, Princeton Junction, NJ (US);
Louis-Charles Campeau, Morris Plains, NJ (US);
Harold B. Wood, Westfield, NJ (US);
Jiayi Xu, Marlboro, NJ (US);
Richard Berger, Harleysville, PA (US);
Jane Yang Wu, Marlboro, NJ (US);
Robert K. Orr, Cranford, NJ (US);
Shawn P. Walsh, Bridgewater, NJ (US);
Bart Harper, New York, NY (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
The present invention provides a compound of Formula I and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing unstable angina, refractory angina, myocardial infarction, transient ischemic attacks, atrial fibrillation, thrombotic stroke, embolic stroke, deep vein thrombosis, disseminated intravascular coagulation, ocular build up of fibrin, and reocclusion or restenosis of recanalized vessels. The compounds are selective Factor IXa inhibitors.